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Ductal growth of the mammary gland occurs in two distinct
stages. The first round of branching morphogenesis occurs during
embryogenesis, and the second round commences at the onset of
puberty. Currently, relatively little is known about the genetic
networks that control the initial phases of ductal expansion,
which, unlike pubertal development, proceeds independent of
hormonal input in female mice. Here we identify NF-κB down-
stream of the TNF-like ligand ectodysplasin (Eda) as a unique reg-
ulator of embryonic and prepubertal ductal morphogenesis. Loss
of Eda, or inhibition of NF-κB, led to smaller ductal trees with
fewer branches. On the other hand, overexpression of Eda caused
a dramatic NF-κB–dependent phenotype in both female and male
mice characterized by precocious and highly increased ductal
growth and branching that correlated with enhanced cell prolifer-
ation. We have identified several putative transcriptional target
genes of Eda/NF-κB, including PTHrP,Wnt10a, andWnt10b, as well
as Egf family ligands amphiregulin and epigen. We developed
a mammary bud culture system that allowed us to manipulate
mammary development ex vivo and found that recombinant
PTHrP, Wnt3A, and Egf family ligands stimulate embryonic branch-
ing morphogenesis, suggesting that these pathways may cooper-
atively mediate the effects of Eda.
hypohidrotic | ectodermal dysplasia | Edar
Mammary gland development is initiated during embryo-genesis, but is completed only on pregnancy to support
lactation. Similar to other skin appendages, such as hair and
teeth, embryonic mammary gland development is guided by
autocrine and paracrine signals mediating tissue interactions
between the ectodermal epithelium and the underlying mesen-
chymal cells, whereas morphogenesis during puberty and preg-
nancy relies on hormonal cues as well (1–4). In mice, mammary
gland development begins at embryonic day (E) 10.5 and pro-
ceeds from placode to bud stage by E14 similarly in both sexes.
However, as a result of androgen receptor (AR) activation in
mesenchymal cells of male embryos at E14, the connection of the
bud to the surface epidermis is severed. Consequently, male mice
have either no ductal system or only a very rudimentary system,
and no nipples (2). Specification of the secondary mammary
mesenchyme also begins at around E14 and gives rise to the fat
pad, which supports the development of mammary glands
throughout postnatal life (5). At E16, the distal tip of the bud
invades the fat pad precursor tissue, and the first bifurcation of
the primary sprout is detected at late E16 or early E17. By birth,
a ductal tree with 10–15 branches has formed. Postnatal growth
of the mammary gland is proportional to the rest of the body
until the onset of puberty, when ovarian activity leads to rapid
acceleration in ductal growth and branching (1–4).
Molecular regulation of hormone-dependent mammary gland
morphogenesis during puberty and pregnancy has been thoroughly
studied over the past several decades (3). In contrast, relatively
little is known about factors driving hormone-independent em-
bryonic and prepubertal ductal outgrowth and branching, although
parathyroid hormone-related protein (PTHrP) and the canonical
Wnt pathway are known to be involved (1, 2). PTHrP, expressed in
the mammary epithelium, is necessary for downgrowth of the
mammary bud, and deficiency in PTHrP or its mesenchymally
expressed receptor PTHR1 leads to a failure in primary sprout
formation (2, 6). The effects of PTHrP are at least partly mediated
by Bmp signaling, as demonstrated by the ability of exogenous
Bmp4 to rescue the phenotype of PTHrP null mammary buds ex
vivo (7). Mice deficient in the Wnt coreceptor Lrp6 exhibit
a stunted, branchless primary duct and a minuscule fat pad at birth
(8). In addition, Egf receptor (Egfr) null mice have fewer branches
and shorter ductal trees at birth (9). The ligands involved in these
features remain elusive, however (10).
Ectodysplasin-A1 (Eda-A1, hereinafter Eda), a member of the
TNF superfamily, is essential for ectodermal organogenesis (11).
Mutations in Eda, its receptor Edar, or the signal mediator
Edaradd cause hypohidrotic ectodermal dysplasia (HED) syn-
drome in both humans and mice. HED in humans is character-
ized by sparse hair, severe oligodontia, absence or reduced
number of sweat glands, as well as defects in other exocrine
glands (11, 12). Intriguingly, transgenic overexpression of Eda
under the keratin 14 promoter (K14-Eda mice) leads to the
formation of supernumerary mammary placodes that give rise to
ectopic glands in adults (13, 14). The Eda pathway was also re-
cently implicated in pubertal mammary gland development (15).
Besides this, little is known about the role of the Eda pathway in
mammary gland development.
Several lines of evidence indicate that many of the effects of
Eda are mediated by transcription factor NF-κB (11). In unsti-
mulated cells, NF-κB is kept inactive by binding to IκB proteins,
most commonly IκBα, in the cytosol (16). On stimulation, IκBα is
phosphorylated and degraded thereby releasing NF-κB and
allowing target gene expression. Studies in cultured cell lines,
identification of similarities in Eda null and IκBαΔN mice
expressing the transdominant superrepressor IκBα, and analysis
of NF-κB reporter expression in Eda−/− embryos have pin-
pointed NF-κB as the key mediator of Eda signaling (11, 17, 18).
Here we identify Eda as a unique mesenchymal factor regulating
embryonic and prepubertal mammary gland morphogenesis
through activation of Edar/NF-κB in the epithelium, and provide
evidence suggesting that PTHrP, Egf ligands amphiregulin (areg)
and epigen (epgn), and Wnt10a and Wnt10b might cooperatively
mediate the effects of Eda.
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Results
Ectodysplasin Regulates Embryonic and Prepubertal Branching
Morphogenesis. In WT embryos, a small ductal tree with an av-
erage of nine branches formed in the fourth (inguinal) mammary
gland by E18. At the same stage, Eda null embryos displayed
a 68% reduction of branches (Fig. 1 A–C). The mean total ductal
length was decreased by 71% (from 3.07 mm ± 0.92 to 0.89 mm ±
0.35; P = 2.8 × 10−8). K14-promoter–driven overexpression of
Eda had the opposite effect and led to a striking fivefold increase
in the number of end buds compared with littermate controls
(Fig. 1 D–F).
At age 3 wk, just before the onset of puberty, Eda−/− mice
exhibited a 54% reduction in the number of ductal termini (Fig.
1 G–I), compared with the almost threefold increase seen in
K14-Eda mice (Fig. 1 J–L). This indicates that the extent of
ductal branching was strongly correlated with the level of
Eda expression.
Eda Overexpression Induces Precocious Branching Morphogenesis.
The highly escalated branching of K14-Eda mammary glands
prompted us to study the course of branching morphogenesis
during embryogenesis. Edar is expressed in the mammary bud
epithelium (19). Before and at the onset of branching morpho-
genesis, Eda transcripts were localized in the mesenchyme,
whereas prominent epithelial expression was observed in K14-
Eda embryos (Fig. S1). NF-κB reporter mice expressing β-ga-
lactosidase under an NF-κB–responsive element displayed high
Eda-dependent NF-κB activity (18) (Fig. S2). We used this NF-
κB reporter mouse to visualize developing mammary glands.
The WT mammary rudiment was relatively quiescent between
E13 and E16 (2, 4) (Fig. 2 A, C, and E). At E13.5–E14.5, both
WT and K14-Eda mammary buds appeared fairly similar (Fig. 2
A and B and Fig. S2). At E15.5, K14-Eda mammary buds had
already elongated and formed first branches (Fig. 2D and Fig.
S2). At E16.5, the WT mammary buds had sprouted, but be-
tween four and six branches had already formed in K14-Eda
embryos (Fig. 2 E and F and Figs. S2 and S3). Sectioning of
whole-mount stained mammary glands confirmed that Eda-de-
pendent NF-κB activity was confined to the epithelium and was
enriched in the basal cells (Fig. 2 A′, C′, and E′). Increased and
ectopic NF-κB activity was observed throughout the epithelium
of K14-Eda embryos (Fig. 2 B′, D′, and F′).
K14-EdaMale Mammary Buds Escape Androgen-Mediated Destruction.
Intriguingly, nipples were observed in K14-Eda males (Fig. S4 A
and B). The ductal tree of the fourth inguinal gland of K14-Eda
males was highly similar to that of female transgenic mice at E18
(Fig. S4 C and D) and 3 wk of age (compare Figs. 3B and 1K),
with 81.6 ± 11.4 ductal tips in the males (n = 12) and 96.5 ± 14.3
in the females (n = 20), whereas no or very rudimentary ductal
structures were observed in control males (Fig. 3A). Further
development of the K14-Eda male ductal system was modest,
however (Fig. S4 E and F). Interestingly, the majority of K14-Eda
male mammary glands developed as blind ducts (Fig. 3B and
Fig. S4F).
In male embryos, androgens secreted by testes activate mes-
enchymally expressed AR at E14 (2, 4, 20). This leads to con-
densation of mesenchymal cells around the stalk of the bud and
triggers apoptosis in the entire mammary anlage (4, 21). No
differences in testis histology, AR expression, activated caspase-3
staining, or mesenchymal condensation in the stalk region were
observed between control and K14-Eda males at E14.5–E15.5
(Fig. 3 C–F and Fig. S5). However, ductal tips of transgenic
glands had invaded through the primary, AR-positive mammary
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Fig. 1. Embryonic and prepubertal branching correlates with the amount of
ectodysplasin. Whole-mount stained fourth inguinal mammary glands of
female Eda−/−, K14-Eda, and their control mice at E18 (A–F) and 3 wk of age
(G–L), and quantification of epithelial branching, expressed as the average
number of ductal tips ± SD per mammary gland in each genotype (C, F, I, and
L). (A and G) B6CBA controls for Eda−/− mice shown in B and H. (D and J)
C57BL/6 littermate controls of K14-Edamice shown in E and K. (C) Number of
ductal tips of control (n = 14) and Eda−/− (n = 10) glands at E18. (F) Number
of ductal tips of control (n = 9) and K14-Eda (n = 12) glands at E18. (I)
Number of ductal tips of 3-wk-old control (n = 28) and Eda−/− (n = 18) mice.
(L) Number of ductal tips of 3-wk-old control (n = 13) and K14-Eda (n = 20)
mice. n, number of glands analyzed. ***P < 0.001. (Scale bars: 500 μm.)
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Fig. 2. Transgenic overexpression of Eda induces precocious branching
morphogenesis and ectopic activation of NF-κB. (A–F) Fourth inguinal
mammary glands of female K14-Eda and their littermate control embryos
were analyzed for NF-κB reporter activity by LacZ whole-mount staining at
E14.5 (A and B), E15.5 (C and D), and E16.5 (E and F). (Scale bar: 200 μm.) (A′–
F′) Sections of whole-mount stained specimens. (Scale bars: 100 μm.)
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mesenchyme by E15.5, and, consequently, only rare apoptotic
cells were detected in the most distal structures (Fig. 3 E and F).
NF-κB Mediates Eda-Induced Ductal Growth and Branching. To ad-
dress the function of NF-κB in embryonic and prepubertal de-
velopment, we exploited the IκBαΔN mouse strain (17).
Expectedly, NF-κB reporter expression was abolished in the
mammary epithelium of IκBαΔN embryos (Fig. S6). The number
of ductal tips was diminished in IκBαΔN embryos by 48% at E18
(Fig. 4 A–C) and by 47% at age 3 wk (Fig. 4 D–F). IκBαΔN mice
are known to be growth-retarded (17), and an average 25% re-
duction in weight was observed at age 3 wk. A highly significant
difference between mutant and control mice also was seen when
the number of ductal termini was normalized to weight, as well as
when IκBαΔN mice were compared with weight-matched con-
trols (Fig. 4F). Eda-induced branching was fully suppressed in
the IκBαΔN background at E18 (Fig. 4 G–J) and 3 wk of age
(Fig. 4 K–N), demonstrating the need for NF-κB downstream of
Eda in ductal morphogenesis.
PTHrP, areg, epigen, Wnt10a, and Wnt10b Are Likely Transcriptional
Targets of Eda.We next sought the mediators of Eda/NF-κB action
in developing mammary glands. We previously performed micro-
array profiling of genes differentially expressed in embryonic Eda−/−
skin after short exposure to recombinant Eda protein (Fc-Eda-A1)
(22, 23). PTHrP (7.5-fold) and the Egfr agonists epgn (6.4-fold) and
areg (4.4-fold) were among the 15 most highly up-regulated genes
after 4 h of Fc-Eda-A1 treatment (23). We also consideredWnt10a
andWnt10b as promising candidates, because both genes have been
identified as likely direct NF-κB target genes in hair germs (24).
Quantitative RT-PCR (qRT-PCR) confirmed the rapid up-regula-
tion of PTHrP, epgn, and areg by Fc-Eda-A1 in skin explants, along
with a modest but reproducible effect on Wnt10a and Wnt10b
mRNA levels (Fig. S7). Treatment of microdissected Eda−/−
mammary buds with Fc-Eda-A1 led to a significant increase in the
levels of Wnt10a, Wnt10b, and PTHrP (Fig. 5A). Areg and epgn
were expressed at low levels, but a tendency toward up-regulation
of their mRNA levels by Fc-Eda-A1 was seen (Fig. 5A). Wnt in-
hibitor Dkk4, a bona fide transcriptional target of Eda/NF-κB
colocalizing with Edar in hair and mammary buds (22–24), was
highly induced (Fig. 5A and Fig. S7).
In situ hybridization analysis of Wnt10b expression before
(E13.5) and during (E15.5) the onset of ductal morphogenesis
revealed a correlation, with a reduction in Eda−/− mammary
buds and an up-regulation in K14-Eda mammary buds (Fig. S8
A–F). Expression of PTHrP also was up-regulated in K14-Eda
buds at E13.5, but no obvious difference between the genotypes
was apparent at E15.5 (Fig. S8 G–L). PTHrP was reduced in
IκBαΔN mammary buds at E13.5 (Fig. S8 M and N). These
findings indicate that expression of PTHrP is not only induced by
Eda (Fig. 5A), but also requires NF-κB. Somewhat surprisingly,
there was no obvious difference in Wnt/β-catenin activity, as
measured with TOP-gal and BAT-gal reporters, or in Lef1 ex-
pression between Eda−/− and control embryos at E14.5 or E15.5
(Fig. S9). Intriguingly, two kinds of changes were observed in
K14-Eda embryos; epithelial activity, particularly Lef1 staining,
was reduced, whereas the number of mesenchymal BAT-gal–
expressing cells was increased, especially at later stages when the
mesenchymal condensate appeared to be more expanded (Fig.
S9 D–F and J–O). In line with qRT-PCR data, both areg and epgn
were barely detectable by in situ hybridization, indicating that
their mRNA levels were low in vivo.
Egf Ligands, PTHrP, and Wnt3A Accelerate Embryonic Ductal Branching
ex Vivo. To assess the functional relevance of the potential Eda
target genes on embryonic branching morphogenesis, we estab-
lished an ex vivo mammary bud culture system that entailed slight
modifications to previously described methods (7, 25). Under this
setup, a remarkable proportion of WT mammary buds gave rise
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destruction. (A and B) Whole-mount stained fourth inguinal mammary
glands of control and K14-Edamale mice at 3 wk of age. (Scale bar: 500 μm.)
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Fig. 4. NF-κB regulates embryonic and prepubertal ductal development and
is essential for Eda-induced accelerated branching morphogenesis. (A and B)
Whole-mount stained fourth inguinal mammary glands of female IκBαΔN
and littermate control mice at E18. (C) Quantification of epithelial branch-
ing, expressed as the average number of ductal tips ± SD per fourth mam-
mary gland in control (n = 13) and IκBαΔN (n = 18) mice at E18. (D and E)
Whole-mount stained fourth inguinal mammary glands of female IκBαΔN
and their littermate control mice at 3 wk of age. (F) Average number of
ductal tips ± SD per fourth mammary gland of 3-wk-old IκBαΔN mice (n = 18)
and littermate controls (n = 13), of 3-wk-old mice normalized to weight
(control, n = 13; IκBαΔN, n = 10), and of 3-wk-old IκBαΔN mice (n = 8)
compared with weight-matched controls (n = 8). (G–N) Whole-mount
stained fourth inguinal mammary glands of female control, K14-Eda,
IκBαΔN, and K14-Eda;IκBαΔN compound mutants at E18 (G–J) and at 3 wk of
age (K–N). n, number of glands analyzed. **P < 0.01; ***P < 0.001. (Scale
bars: 500 μm.)
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to successful branching outgrowths, with success rates of 90% for
NMRI (29 of 32) and B6CBA (70 of 79) and 70% for C57BL/6
(23 of 29) (Fig. 5 B, D, and G). Mammary buds isolated from
K14-Eda embryos (in C57BL/6) were readily cultured ex vivo and
recapitulated the in vivo phenotype (Fig. 5C). Only 15% (19 of
144) of buds dissected from Eda−/− embryos (in B6CBA) gave
rise to successful outgrowths (Fig. 5 E and G), and the rudiments
typically regressed before sprouting. However, application of Fc-
Eda had a prominent restorative effect on Eda−/− mammary
buds, and approximately half of the buds (74 of 156) sprouted
and branched (Fig. 5 E–G).
We first tested the effect of recombinant PTHrP, areg, epgn,
and Wnt3A (a representative of canonical Wnt ligands) on WT
buds, which formed an average of three branches after 5 d of
culture (Fig. 5 H andM). Application of PTHrP or of either Egfr
agonist doubled the number of end buds (Fig. 5 H–K and M).
Wnt3A had a positive effect of the same range (Fig. 5 L and M).
However, none of these factors given alone or in combination
had any discernible impact on the success rate of Eda−/− bud
outgrowths (Fig. 5 N–S).
Eda Enhances Cell Proliferation but Has No Effect on Apoptosis in
Vivo. The significantly increased ductal growth of K14-Eda
mammary glands and the reduced growth of Eda−/− glands
suggests that Eda can promote epithelial cell proliferation,
protect these cells from apoptosis, or both. No significant dif-
ference in activated caspase-3 staining was seen in epithelial cells
of E15.5 Eda−/−, WT, and K14-Eda buds (Fig. 6 A and B).
Cell proliferation was assessed at 2 h after injection of the
nucleoside analog 5-ethynyl-2′-deoxyuridine (EdU) at E14.5 by
whole-mount staining for EdU and EpCAM, a marker of epi-
thelial cells (Fig. 6C). The number of epithelial (EpCAM+)
EdU-positive cells, normalized to bud volume (Fig. 6D), was
significantly higher in K14-Eda buds compared with controls
(Fig. 6E). No differences in mesenchymal cell proliferation were
detected at this stage (Fig. 6F). Similar findings were observed
when ex vivo cultured mammary buds were analyzed, except that
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of the indicated genes in E13.5 Eda−/−mammary buds (n = 8–9) treated with recombinant Fc-Eda protein for 4 h. Data are mean ± SD. (B–F) Mammary buds of
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−/− = 33) (K and Q), or 100 ng/mL of Wnt3A (nwt = 10; nEda
−/− = 66) (L and R). (M) Number of ductal tips ± SD of WT mammary buds
cultured in medium supplemented with factors indicated in (H–L). (S) Quantification of the frequency of successful bud outgrowths of Eda−/−mammary buds
cultured in medium supplemented with factors indicated in (N–R). ns, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.
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notable changes were seen in mesenchymal cell proliferation as
well (Fig. S10).
Discussion
The embryonic development of the mammary gland is regulated
by crosstalk between the ectodermal epithelium and two types
of mesenchymal tissues: the primary condensed mesenchyme,
which has the capability to induce mammogenesis even when
combined with nonmammary epithelium, and the prospective
fat pad tissue, which supports ductal outgrowth and dictates
organ-specific branching patterns (4, 26). Pioneering tissue
recombination experiments have indicated that mammary
branching morphogenesis is regulated largely by mesenchymal
signals (5, 25, 26), which might act as either survival/pro-
liferative cues or guidance factors. With the exception of Fgf10
(27), the identity of these mesenchymal signals has remained
elusive. Here we identify Eda as a mesenchymal factor regu-
lating embryonic morphogenesis via activation of Edar
in epithelial basal cells. However, modulation of the Eda path-
way activity did not seem to affect branching pattern per se, but
rather affected cell proliferation (see below). Likewise, we
recently discovered that the extent of submandibular salivary
gland branching is correlated with Eda/NF-κB activity, yet
Eda−/− and K14-Eda glands retain the typical salivary gland-type
branching pattern (28).
Our data reveal a previously unrecognized function for NF-κB
in embryonic mammogenesis. A role for NF-κB in pubertal de-
velopment has been inferred from studies showing that trans-
plantation of IκΒα-deficient epithelium into cleared fat pads of
WT mice resulted in a substantial increase in branching (29) and
that mouse mammary tumor virus-driven expression of a non-
degradable I-κBα implicated NF-κB in pregnancy-associated side
branching (30). Thus, tight control of NF-κB activity is necessary
at several stages to ensure correct mammary gland development.
It is well established that NF-κB can promote cell proliferation
and/or suppress apoptosis (16). Based on EdU incorporation and
cleaved caspase-3 staining, we find it likely that the Eda/NF-κB
pathway exerts its function during embryonic ductal morpho-
genesis via its ability to enhance proliferation, similar to findings
in IκBα-deficient mammary epithelia during puberty (29). The
ability of Eda/NF-κB to enhance cell proliferation may result
from a direct impact on signal-receiving cells and/or indirect
impacts via autocrine or paracrine effects. At E14.5, just when
the differences between K14-Eda and control buds are emerging,
K14-Eda buds exhibited highly increased epithelial cell pro-
liferation. Ex vivo studies have suggested that mesenchymal cell
proliferation also may be affected, but perhaps moreso at later
time points.
We identified several secreted factors—Egfr ligands, Wnt10a
and Wnt10b, and PTHrP—as putative target genes of Eda.
These factors accelerated branching of embryonic mammary
glands ex vivo, suggesting that they may contribute to the ob-
served Eda loss-of-function and gain-of-function phenotypes,
although additional Eda target genes are bound to be involved.
The relative significance of distinct Eda target genes may differ
in Eda−/− and K14-Eda mammary glands, however. Studies in
other ectodermal organs have revealed a tight but complex re-
lationship between Eda/NF-κB and Wnt/β-catenin pathways (11,
24, 28). Our data suggest that Eda overexpression may lead to
both decreased (epithelium) and increased (mesenchyme)
changes in Wnt/β-catenin signaling. We speculate that these dual
effects might be due to up-regulation of two kinds of paracrine
Wnt factors: Wnt agonists (Wnt10a and Wnt10b) and Wnt in-
hibitor Dkk4. These findings raise the intriguing possibility that
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enhancement of mesenchymal Wnt signaling, suppression of
epithelial Wnt signaling, or both are linked to accelerated
branching morphogenesis. The elucidation of the functional
importance of epithelial and mesenchymal Wnt/β-catenin sig-
naling must await the generation of inducible, tissue-specific
β-catenin–deficient mice.
Sexual dimorphism of embryonic mammogenesis, observed in
mice and some other rodents, depends on AR expression
downstream of PTHrP (2, 4, 21). We detected all of the hall-
marks of AR activation in the K14-Eda males. Accordingly, the
connection between the prospective nipple and the ductal bulb
was severed in most cases. However, the entire anlage was not
destroyed, most likely because of the precocious growth of the
ductal tip(s) into the underlying secondary, AR negative stroma.
Interestingly, Wnt1 and Wnt10b transgenes also can overcome
the androgen-dependent developmental block and display ex-
tensive ductal hyperplasia (31, 32).
In conclusion, this study has identified the role of a unique
TNF pathway in mammary gland morphogenesis. Thus, two
different TNF pathways are now emerging as important mito-
genic regulators of distinct stages of mammary gland de-
velopment: the Eda/Edar/NF-κB pathway as a driver of
hormone-independent ductal growth and branching, and the
RANK pathway as the essential mediator of progesterone-in-
duced proliferation and side branching during pregnancy (33).
Reports on breast defects of patients with HED are scattered
(34, 35) but, taken together with our present findings, suggest
that Eda is an important regulator of human breast development
as well. Elevated levels of NF-κB activity have been associated
with breast cancer, particularly with hormone-independent
tumors with poor prognosis, but the molecular mechanisms
leading to constitutive NF-κB activation remain incompletely
understood (36, 37). Future studies should examine whether Eda
plays any role in breast tumorigenesis.
Materials and Methods
Embryonic mammary bud cultures were prepared according to a protocol
modified from the techniques described by Kratochwil (25) and Hens et al.
(7). The ventral skin encompassing the mammary line area was dissected
from E13.5 embryos, explants were treated for 4–8 min with 0.75% pan-
creatin and 0.25% trypsin (Sigma-Aldrich) at room temperature. After a 1-h
incubation on ice in DMEM supplemented with 10% (vol/vol) FCS, 2 mM
L-glutamine, and antibiotics, excess epithelium surrounding the mammary
buds was microsurgically peeled off. A typical explant consisted of an ample
amount of mesenchyme with mammary buds 2, 3, and 4 attached. Explants
were cultured for 5–6 d in a Trowell-type culture setting (14, 22) in 1:1 F12/
DMEM with the same supplements as above and ascorbic acid (75 mg/L). The
medium was changed every other day.
Details on animals, recombinant proteins, qRT-PCR, in situ hybridization,
EdU labeling, immunofluorescence, and confocal microscopy are provided in
SI Materials and Methods.
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